India manages to limit COVID to 3,328 cases and 55 deaths per million population: Harsh Vardhan
File photo of Health Minister Harsh Vardhan speaking in the Lok Sabha in New Delhi on February 10, 2020.IANS

India manages to limit COVID to 3,328 cases and 55 deaths per million population: Harsh Vardhan

New Delhi, September 14, 2020

Union Minister for Health & Family Welfare Harsh Vardhan today said India has managed to limit the COVID cases to 3,328 per million and deaths to 55 per million population, among the lowest in the world, by taking several pro-active measures.

”With our endeavour to manage COVID-19 through a ‘whole of government and whole of society’ approach, India has been able to limit its cases and deaths per million," he said in a suo motu statement on the pandemic in the Lok Sabha on the first day of the monsoon session of Parliament.

“As on September 11, 215 countries/territories worldwide are affected. As per WHO, there are more than 2.79 crore confirmed cases across the world with more than 9.05 lakh deaths, with a case fatality rate of 3.2%.

“A total of 45,62,414 confirmed cases and 76,271 deaths (Case Fatality Rate 1.67%) have been reported in India. As many as 35,42,663 (77.65%) cases have recovered. The maximum cases and deaths have been primarily reported from Maharashtra, Andhra Pradesh, Tamil Nadu, Karnataka, Uttar Pradesh, Delhi, West Bengal, Bihar, Telangana, Odisha, Assam, Kerala and Gujarat. All these States have reported more than one lakh cases,” he added.

“The increasing magnitude of this outbreak in India called for a pre-emptive, pro-active, graded, whole-of-government, whole-of-society approach, built around a comprehensive strategy to prevent infections, save lives and minimize impact,” the Minister said.

“The Government of India undertook the COVID-19 challenge with the highest level of political commitment. The nationwide lockdown, a bold decision by the Government duly involving the community, initiated as self-imposed Janata Curfew as per the call given by Prime Minister Narendra Modi is testimony to the fact that India has collectively stood up to manage COVID-19 and successfully blunted Its aggressive progression.

"It has been estimated that this decision prevented approximately 14–29 lakh cases and 37,000–78,000 deaths. These four months were utilized to create additional health infrastructure, enhance human resources and produce within India critical elements such as PPEs, N-95 masks and ventilators.

“A case in point is the increase in dedicated isolation beds 36.3 times and dedicated ICU beds above 24.6 times to what existed in March 2020. Whereas there was no indigenous manufacturing of PPE, with the requisite standards, we are now self-sufficient and, in a position, to even export the same,” he added.

“We have now moved from ‘managing travel-related cases’ to containing clusters and large outbreaks due to local transmission to the widespread infection to urban, peri-urban and rural areas. This would require a concerted effort by the Government with people’s participation to prevent large scale morbidity and mortality.

“Equally crucial is to maintain the success achieved in the management of reproductive maternal and child health, vaccine-preventable diseases, non-communicable diseases, tuberculosis, vector-borne diseases such as Kala Azar and Malaria. Hence there is an increased thrust for managing non-COVID essential services,” Dr Harsh Vardhan said.

“I would urge all Members of Parliament that the battle for COVID is still far from over. On one hand, when we are in the stage of Unlock to revive the economy, and have a balanced approach, sustained community support must be ensured consistently to control the spread of infection & break its chain of transmission.

“Your support is crucial to create awareness in your respective constituencies for COVID Appropriate Behaviour. The simple public health measures of wearing of mask/face covers, frequent hand washing, respiratory etiquettes, and physical distancing '2-Gaj Ki Doori' as a social vaccine, if practised responsibly, will help us control/suppress the transmission of COVID,” he added.

The Government has initiated a series of actions to prevent and to contain the disease. The Minister said he was reviewing the situation daily. The Prime Minister himself has interacted with the Chief Ministers of all States and UT administrations and all stakeholders to regularly understand issues and collaborate with the States for effective management, he said.

The Group of Ministers under the Health Minister’s chairmanship comprising Minister of External Affairs, Minister of Civil Aviation and Minister of State for Home Affairs, Minister of State for Shipping and Minister of State for Health & Family Welfare, has met 20 times since its inception on February 3, he said.

The Committee of Secretaries under Cabinet Secretary has taken regular reviews with all related Ministries of Health, Defence, Ministry of External Affairs, Civil Aviation, Home, Textiles, Pharma, Commerce and other officials including with State Chief Secretaries.

The Ministry of Home Affairs constituted 11 Empowered Groups on March 29 on different aspects of COVID-19 management to make informed decisions on issues ranging from medical emergency planning, availability of hospitals, isolation and quarantine facility, disease surveillance and testing, ensuring the availability of essential medical equipment, augmenting human resource and capacity building, supply chain and logistics management.

Coordination with the private sector, economic and welfare measures, information, communications and public awareness, technology and data management, public grievance and strategic issues related to lockdown also figured in the discussions. These groups were restructured on September 10 based on the need and evolving scenario, he said.

“My own Ministry is constantly reviewing the evolving scenario. Video conferences are being held with States regularly. We have held 63 video conferences so far with State Health Ministers, Health functionaries and district level officials. The Joint Monitoring Group (JMG) under the Chairmanship of DGHS which advises the Health Ministry on technical matters has met 40 times till now to assess the risk, review the preparedness & response mechanisms and finalize technical guidelines,” the Minister said.

The Union Government, based on its experience of successfully managing pandemics and epidemics in the past, provided the requisite strategy, plans and procedures to the State Governments and UT administrations. These included containment plans and guidelines on a wide range of subjects related to travel, behavioural & psycho-social health, surveillance, laboratory support, hospital infrastructure, clinical management, rational use of Personal Protective Equipment (PPE) etc. including inspirational guidance for healthcare personnel.

It has also taken several other measures to contain/suppress the transmission of COVID. The first Travel Advisory was issued on January 17 and as the situation evolved, these were revised in a graded manner. Universal screening of passengers from all countries was introduced and up to March 23 (till suspension of all commercial flights), a total of 14,154 flights with 15,24,266 passengers were screened at the airports.

In addition to airports, about 16.31 lakh people were screened at land border crossings and about 86,379 people were screened at 12 major and 65 minor seaports.

At present, the Government has advised that no scheduled international commercial passenger aircraft be allowed to take off from any foreign airport for any airport in India, from March 22, except under the Vande Bharat Mission from May 7, which aims to bring home stranded Indians in many countries due to the pandemic.

Temporary air travel arrangements (Transport Bubbles) between India and nine other mutually consenting countries aimed at restarting commercial passenger services have commenced. These were reciprocal, meaning airlines from both countries enjoy similar benefits. The "Guidelines for International Arrivals" issued by the Ministry on May 24 were revised on August 2.

Before the lockdown 1.0, the Government evacuated Indian nationals from Wuhan inChina, Diamond Princess Cruise Ship, Japan, Iran, Italy and Malaysia. Under Vande Bharat Mission, as reported on September 11, a total of 12,69,172 passengers have been brought back to India.

Community surveillance was initiated initially for travel-related cases and subsequently for cases being reported from the community by Integrated Disease Surveillance Programme (IDSP). As on September 11, a total of about 40 lakh people have been kept under surveillance and extensive contact tracing of all positive cases was regularly being undertaken through disease surveillance network to break the chain of transmission.

The Ministry of Health & Family Welfare released containment plans to contain cluster and large outbreaks on March 2 and April 4 respectively and these plans were updated from time to time. The containment plans envisage a strategy of breaking the chain of transmission by defining containment and buffer zones, applying strict perimeter control, intensive active house to house search for cases and contacts, isolation and testing of suspect cases and high-risk contacts, quarantine of high-risk contacts, intensive risk communication to raise community awareness on simple preventive measures and the need for prompt treatment-seeking and strengthening of passive Influenza-Like Illness (ILI)/ Severe Acute Respiratory Illness (SARI) surveillance in containment and buffer zones, he said.

The Minister said that, with the evolving scenario, the laboratory network was continuously being strengthened. From a situation of a single laboratory equipped to undertake testing for COVID in January, at present, 1705 laboratories are conducting COVID-19 Testing. Laboratories have been established in difficult terrains like Ladakh, Sikkim, Arunachal Pradesh, Nagaland as well as other North-Eastern states, Lakshadweep and Andaman & Nicobar Islands.

Currently, the testing is about 1 million tests a day (which translates to 720 tests per million population per day), much higher than that stipulated by WHO which is 140 tests per million population per day. A total of 5,51,89,226 samples have been tested so far as on September 11.

“While there were no indigenous manufacturers of laboratory diagnostics or testing machines for COVID, today we have an indigenous production capacity of more than 10 lakh kits/day,” Dr Harsh Vardhan said.

For appropriate management of COVID-19 cases, a three-tier arrangement of health facilities comprising COVID Care Centre with isolation beds for mild or pre-symptomatic cases; Dedicated COVID Health Centre (DCHC) with oxygen supported isolation beds for moderate cases and Dedicated COVID Hospital (DCH) with ICU beds for severe cases has been implemented. Tertiary care hospitals under ESIC, Defence, Railways, paramilitary forces, Steel Ministry etc. have been leveraged for case management.

As on September 12, a total of 15,284 COVID treatment facilities with 13,14,646 dedicated isolation bed without O2 have been created. Also, a total of 2,31,093 oxygen supported isolation beds and 62,717 ICU beds (including 32,575 ventilator beds) have been created.

"Constant monitoring of the disease trend, analysis of available infrastructure and planning in advance for the future has averted a major crisis as was faced by many developed countries. Also, a total of 12,826 quarantine centres with 5,98,811 beds have been created," the Minister said.

Guidelines on clinical management of COVID-19 were issued and regularly updated and widely circulated. These include case definition, prevention of infection control, laboratory diagnosis, early supporting therapy, management of severe cases and complications.

No specific antivirals have been proven effective so far. Symptomatic treatment for fever and cough, appropriate rehydration, supplemental oxygen therapy remains the mainstay of treatment. “We have re-purposed the drug hydroxychloroquine for mild (but high-risk cases) and for moderate cases. This was done with limited scientific evidence but well acknowledging that this drug has been used widely in India for other ailments where it is used for prolonged periods, with good safety profile.

“Also, provisions for investigational therapies has also been made for using Remdesivir, Convalescent plasma and Tocilizumab for managing severe cases under close medical supervision,” he added.

With the intent to ensure dissemination of these standard treatment protocols and reduce mortality to the maximum extent, several initiatives have been launched. An AIIMS Coronavirus helpline 9971876591 has been started to guide the doctors on medical management. AIIMS Delhi is running the COVID-19 National Tele-consultation Centre (CoNTeC) which can be reached by calling +91-9115444155. It is catering to doctors, from anywhere in the country, who want to consult AIIMS faculty for the management of COVID-19 patients, as well as to the public in general.

Telemedicine guidelines were issued on March 25 to provide teleconsultation to patients for mitigation of their illness and prevention of crowding in clinics. It may also help in triage, treatment and counselling for the care of ill patients by healthcare providers in areas with limited access.

A clinical Centre of Excellence (CoE) initiative has also been launched by the Ministry with AIIMS, Delhi as apex nodal institution and State level CoEs to guide clinical management protocols. Weekly webinars were being organized by AIIMS to guide these State-level CoEs on crucial clinical issues that doctors may require guidance on managing COVID cases. These State-level CoEs are expected to further disseminate these in their districts.

To ensure accessibility of quality treatment for both COVID and non-COVID health issues in far-flung areas, use of telemedicine has been promoted in a big way. 'eSanjeevani', a web-based comprehensive telemedicine solution is being utilized (in 23 states) to extend the reach of specialized healthcare services to masses in both rural areas and isolated communities.

ICMR was establishing a National Clinical Registry on COVID that will provide insights into the clinical course of COVID-19 disease, its spectrum and outcome of patients.

Thirteen clinical trials of repurposed drugs and harnessing of traditional knowledge using the modern medicine approach were building a portfolio of therapeutic options for COVID-19 patients. Phase 2 clinical trial of immunomodulator Sepsivac has been completed successfully. Phase 2 clinical trial of the first-ever phytopharmaceutical ACQH was underway. One prophylactic trial of Aswagandha and three trials of Guduchi + Pippali; Yashtimadhu; and polyherbal AYUSH drug (AYUSH-64) were planned on moderately ill COVID-19 patients.

“An effective vaccine would be the sure-shot tool in the armamentarium against this disease. On this front, globally, there are around 145 candidate vaccines in the preclinical evaluation and currently 35 vaccines in the clinical trial. In India, a major focus has been on facilitating the development of COVID19 vaccine. More than 30 vaccine candidates have been supported which are in different stages of development, 3 candidates are in an advanced stage of Phase I/II/III trials and more than 4 are in the advanced pre-clinical development stage,” the Minister said.

COVID-19 Biorepositories has been set up, which have collected more than 40,000 samples and made available to researchers and industry for developing diagnostics, therapeutics and vaccines.

To coordinate procurement and distribution of the vaccine, the Government of India has constituted a National Expert Group on Vaccine Administration for COVID-19 on August 7, under the Chairmanship of Member (Health), NITI Aayog.

Ministry of AYUSH has contributed through various measures for the management and mitigation of COVID-19. The Ministry recommended guidelines of self-care for preventive health measures and boosting immunity. The Ministry has also issued health advisories from different systems of medicine on prophylaxis and immunity promotion which was translated into eight foreign languages and circulated to Indian Embassies.

Various AYUSH Hospitals were designated as quarantine centres, isolation centres, COVID Care Centres and COVID Health Centres. Around 8.5 lakh Ayush healthcare professionals have been registered on

Ministry of AYUSH has formed an “Inter-disciplinary AYUSH R&D Task Force”. The Task Force has formulated and designed clinical research protocols for AYUSH prophylactic studies and add-on interventions in COVID-19 positive cases. AYUSH-CSIR collaborative studies were initiated with AYUSH medicines for prophylaxis/treatment.

A large-scale population-based study through AYUSH Research Councils and National Institutes under the Ministry on prophylaxis of AYUSH interventions in targeted populations in containment zones was underway. The Ministry has also initiated an impact assessment of effectiveness, acceptance and usage of AYUSH advisories & measures in prevention of COVID 19 through a mobile application app known as AYUSH-Sanjivani app.

States have been requested to assess the stock of their logistic, particularly Personal Protective Equipment and procure the same. Total orders for 1.92 crore PPEs have been placed by the Central Government so far. The Ministry has already supplied 1.39 Crore PPE Kits and 3.43 crore N95 masks to States (as on September 11).

Department of Pharmaceuticals increased the production of drug hydroxychloroquine manifold. As on September 11, the Health Ministry has issued 10.84 crore tablets of Hydroxychloroquine to States/UTs. India has also exported it to more than 140 countries.

The Central Government has already issued orders to purchase 60,948 ventilators to meet any contingencies. As on September 11, 32,109 ventilators have been allocated to States of which 30,170 have been delivered.

The country is self-sufficient in oxygen and oxygen cylinders. Ministry of Health &Family Welfare has procured & supplied 1,02,400 oxygen cylinders to various States/UTs so far. Also, oxygen concentrators were being supplied to the States.

One of the major challenges was to identify and train a large number of COVID warriors across sectors and departments that can be involved in not only COVID related work but also for ensuring maintenance of other essential medical services. Pooling manpower resources has been done from Defence, AYUSH, NCC, NSS, NYK, public sector enterprises, and the private sector.

“Despite various constraints and challenges, the COVID warriors rose to the occasion in serving humanity. The country feels indebted to the doctors, nurses, paramedics, frontline field workers, security and police personnel, sanitary workers, volunteers and journalists who have worked tirelessly to protect our countrymen from the pandemic.

“I would request the August House to place on record the appreciation for the yeoman services delivered by them,” the Minister said.

There had been instances where healthcare service personnel had to face harassment, acts of violence, intimidation and danger to life during discharge of their duties. To overcome this and support their efforts, the Government promulgated the Epidemic Diseases (Amendment) Ordinance, 2020 on April 22.

To build the capacities of human resources including the medical manpower who help to manage patients in hospitals; as well as non-medical personnel and field workers involved in surveillance, logistics etc., modules have been made available on iGOT-Diksha (online platform) by DOPT (

The training modules have been translated into regional languages. Close to 29.15 lakh people have registered for various courses. This includes 5,699 doctors, 86,018 Ayush Professionals, 4,102 Nurses, 963 Allied Health Professionals, 5,881 frontline workers, 2,70,736 volunteers and 25,42,892 other participants.

About 18.96 lakh course completions have taken place on iGOT–Diksha platform. Training Resources for medical and non-medical personnel have also been made available on the website of Ministry of Health & Family Welfare.

The Ministry’s website was being updated daily to provide the general public with information on the current status of COVID-19 spread in India. Regular press releases were being issued and press briefings held.

Communication material and toolkits have been developed (pamphlets, poster, audio and AV films) and provided to the States/UTs on COVID-19 disease, preventive steps required to be taken by the communities, handling of myths and stigma related to disease and to widely publicize the helpline numbers available. Communication material is also being hosted on the website and through social media.

Dos and Don’ts were being widely circulated through SMS (550 crore SMSs have been sent). Caller-tune messages are being sent to telecom subscribers in 13 languages and 117 crore subscribers have been reached.

A dedicated call centre/helpline (1075) had been started in the initial days to guide community at large which is being used by the citizens very effectively and regularly. A total of 41.04 lakh calls have been received so far.

Department of Bio-Technology, Department of Science and Technology, CSIR and Department of Health Research covered the entire chain of scientific and technological solutions holistically for COVID-19 through academia, R&D labs, industry, startups and NGOs.

These solutions include basic scientific studies on the behaviour, transmission and effects of the virus, mathematical modelling of the pandemic, and products such as the world-class ventilators, diagnostic kits, vaccines, therapeutics, antiviral coatings, disinfectants, PPEs, masks, mobile testing booths and hospitals, artificial intelligence-based tools, and information dissemination to masses.

“For these purposes, a comprehensive mapping of our entire startup ecosystem was done to identify and support over 110 technology startups and over 20 industries for commercial production. Over 150 projects in all areas of virus behaviour have been initiated.

The Government was regularly coordinating with WHO headquarters, regional office and country office to get updates on the evolving scenario. It has also provided support to other countries in tackling the challenge posed by the pandemic. India has played a major role in shaping up G20 and BRICS response to COVID. India is also extending support wherever required to neighbouring SAARC countries.

“The Government is proactively identifying gaps and building an Atmanirbhar Bharat that will be able to take challenges of similar pandemics, epidemics and disasters in future. An Expenditure Finance Memorandum of Rs 65,560.98 Crores under Prime Minister Atmanirbhar Swasth Bharat Yojana for strengthening is under consideration. This includes investment in research, healthcare and public health infrastructure with particular focus on pandemic management,” Dr Harsh Vardhan added.


Related Stories

No stories found.

Latest Stories

No stories found.

Trending Stories

No stories found.